Drug Trial Radar · NCT07371728
Effect of Aprepitant on Post-operative Nausea and Vomiting in Otologic Surgery
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
100
Planned (sponsor's estimate)
Start
Oct 15, 2026
Primary completion
Jun 1, 2027
Study completion Jun 1, 2028
Sponsor
- Lead sponsor
- Sir Mortimer B. Davis - Jewish General HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- Jan 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This project is being carried out to study the use of a medication to reduce nausea and vomiting after ear surgery.
Conditions
- Otologic Disease
Interventions
AprepitantDrug
Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. Oral aprepitant of 80mg will be administered within an hour of induction for an otological surgery.
PlaceboOther
Participants will be randomly assigned to the intervention or control group in a 1:1 ratio. An oral placebo capsule will be administered within an hour of induction for an otological surgery.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Incidence of clinically important postoperative nausea and vomitingTime frame: 6h to 48h postoperatively
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Jewish General Hospital
Montreal, Quebec, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.